CRYO CELL INTERNATIONAL INC CCEL revenue by segment, product and geography
In its fiscal year ending 2025-11-30, CRYO CELL INTERNATIONAL INC reported revenue across 3 business segments; the largest, Umbilical Cord Blood And Cord Tissue Stem Cell Service, was $31.4M, 99.4% of the filed sum (-0.5% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Umbilical Cord Blood And Cord Tissue Stem Cell Service$31.4M99.4%-0.5% yoy
- Public Cord Blood Banking$130K0.4%-64.7% yoy
- Prepacytecb$54.1K0.2%-20.3% yoy
Members sum to the consolidated $31.6M for this period.
- Umbilical Cord Blood And Cord Tissue Stem Cell Service$5.41M1121.8%+31.0% yoy
- Public Cord Blood Banking-$4.94M-1024.8%+664.6% yoy
- Prepacytecb$14.2K2.9%-385.5% yoy
Members sum to the consolidated $482K for this period.
- Processing And Storage Fees$31.4M99.4%-0.5% yoy
- Public Banking$130K0.4%-64.7% yoy
- Product$54.1K0.2%-20.3% yoy
Members sum to the consolidated $31.6M for this period.
- Umbilical Cord Blood And Cord Tissue Stem Cell Service$7.72M99.2%-2.0% yoy
- Public Cord Blood Banking$46.5K0.6%+8.9% yoy
- Prepacytecb$14.2K0.2%-1.8% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.